Impedimed Ltd Total Liabilities
Impedimed Ltd total liabilities. Based on the latest financial reports, Impedimed Ltd (IPD) has total liabilities worth AU$24.47 Million AUD (≈ $17.32 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Impedimed Ltd (IPD) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Impedimed Ltd (2006–2026)
Total liabilities of Impedimed Ltd from 2006 to 2026. This chart illustrates how Impedimed Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Impedimed Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Impedimed Ltd Competitors by Total Liabilities
The table below lists competitors of Impedimed Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lithium Plus Minerals Ltd
AU:LPM
|
Australia | AU$369.68K |
|
CodeLab Capital A/S
OL:CODE
|
Norway | Nkr35.15 Million |
|
Sheffield Resources Ltd
AU:SFX
|
Australia | AU$226.00K |
|
General Environmental Conservation Public Company Limited
BK:GENCO
|
Thailand | ฿271.36 Million |
|
Modernland Realty Ltd Tbk
JK:MDLN
|
Indonesia | Rp9.42 Trillion |
|
NowVertical Group Inc
V:NOW
|
Canada | CA$41.35 Million |
|
SAG Holdings Limited
NASDAQ:SAG
|
USA | $30.72 Million |
Liability Composition Analysis (2006–2026)
This chart breaks down Impedimed Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IPD asset base.
Liquidity & Leverage Metrics
Impedimed Ltd Total Liabilities Ratios Explained
Impedimed Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Impedimed Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Impedimed Ltd (2006–2026)
The table below shows the annual total liabilities of Impedimed Ltd from 2006 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | AU$24.47 Million ≈ $17.32 Million |
+15.64% |
| 2025-06-30 | AU$21.16 Million ≈ $14.97 Million |
+239.00% |
| 2024-06-30 | AU$6.24 Million ≈ $4.42 Million |
-20.54% |
| 2023-06-30 | AU$7.86 Million ≈ $5.56 Million |
+2.64% |
| 2022-06-30 | AU$7.66 Million ≈ $5.42 Million |
-11.92% |
| 2021-06-30 | AU$8.69 Million ≈ $6.15 Million |
+52.39% |
| 2020-06-30 | AU$5.70 Million ≈ $4.04 Million |
-16.08% |
| 2019-06-30 | AU$6.80 Million ≈ $4.81 Million |
+17.88% |
| 2018-06-30 | AU$5.76 Million ≈ $4.08 Million |
+3.95% |
| 2017-06-30 | AU$5.55 Million ≈ $3.92 Million |
+4.33% |
| 2016-06-30 | AU$5.32 Million ≈ $3.76 Million |
+72.60% |
| 2015-06-30 | AU$3.08 Million ≈ $2.18 Million |
+115.99% |
| 2014-06-30 | AU$1.43 Million ≈ $1.01 Million |
+12.28% |
| 2013-06-30 | AU$1.27 Million ≈ $898.61K |
-44.88% |
| 2012-06-30 | AU$2.30 Million ≈ $1.63 Million |
+8.58% |
| 2011-06-30 | AU$2.12 Million ≈ $1.50 Million |
-20.82% |
| 2010-06-30 | AU$2.68 Million ≈ $1.90 Million |
-11.58% |
| 2009-06-30 | AU$3.03 Million ≈ $2.14 Million |
+36.85% |
| 2008-06-30 | AU$2.21 Million ≈ $1.57 Million |
-7.16% |
| 2007-06-30 | AU$2.39 Million ≈ $1.69 Million |
-74.38% |
| 2006-06-30 | AU$9.31 Million ≈ $6.59 Million |
-- |
About Impedimed Ltd
ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed fo… Read more